New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2013
08:40 EDTROSGRosetta Genomics reports first payment from UK NHS for Cancer Origin Test
Rosetta Genomics announces that the National Health Service, or NHS, of the United Kingdom, has made its first payment to the company for use of the Rosetta Cancer Origin Test on a British citizen. The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decisions to maximize patient outcomes.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
08:32 EDTROSGRosetta Genomics announces data published in Leukemia Research
Subscribe for More Information
April 17, 2015
10:00 EDTROSGOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CECO Environmental (CECE) upgraded on several positive catalysts at Roth Capital... EMC (EMC) upgraded to Outperform from Market Perform at Bernstein... Fleetmatics (FLTX) upgraded to Overweight from Neutral at Piper Jaffray... NorthStar Asset Management (NSAM) upgraded to Buy from Hold at MLV & Co.... Penn National (PENN) upgraded to Overweight from Neutral at JPMorgan... Rosetta Genomics (ROSG) upgraded to Buy from Hold at Cantor... Ulta Salon (ULTA) upgraded to Buy from Neutral at Nomura... Xcel Energy (XEL) upgraded to Buy from Hold at Argus.
09:14 EDTROSGOn The Fly: Pre-market Movers
Subscribe for More Information
06:33 EDTROSGRosetta Genomics upgraded to Buy from Hold at Cantor
Subscribe for More Information
April 16, 2015
11:16 EDTROSGRosetta Genomics receives patent allowance for cancer of origin diagnostic assay
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use